An investigator's introduction to statistical considerations in clinical trials

被引:2
|
作者
Winter, Kathryn [1 ]
Pugh, Stephanie L. [1 ]
机构
[1] ACR, NRG Oncol Stat & Data Management Ctr, Philadelphia, PA 19103 USA
关键词
Statistical considerations; Determining sample size; Analyses; ANDROGEN DEPRIVATION; RADIOTHERAPY;
D O I
10.1016/j.urolonc.2018.12.025
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this paper is to provide an introduction for investigators to many of the statistical considerations for clinical trials that will aid in their collaborations with statisticians for clinical trial research endeavors and when reading the clinical trials literature. The purpose of this paper is not to turn a physician into a statistician, that takes formal training and education, as well as day in and day out immersion in the statistical design and analysis of clinical trials, hence statistician as a profession. Successful clinical trials, not to be confused with only positive clinical trials, are ones that are well designed to answer the trial question, well conducted, and appropriately reported and published, regardless of the results. Physicians and statisticians each play integral roles in the realm of clinical trials and successful clinical trials are the result of collaborations between physicians and statisticians from the beginning of an idea through the manuscript publication. (C) 2018 Published by Elsevier Inc.
引用
收藏
页码:305 / 312
页数:8
相关论文
共 50 条
  • [1] SECONDARY ANALYSES IN CARDIOVASCULAR CLINICAL TRIALS - STATISTICAL AND OTHER CONSIDERATIONS Introduction
    Tilley, Barbara C.
    Davis, Barry R.
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 2012, 54 (04) : 329 - 329
  • [2] STATISTICAL CONSIDERATIONS IN CLINICAL-TRIALS
    MILLER, JP
    [J]. MUSCLE & NERVE, 1990, 13 : S43 - S44
  • [3] STATISTICAL CONSIDERATIONS IN DESIGN OF CLINICAL TRIALS
    CLARK, C
    [J]. ACTA DERMATO-VENEREOLOGICA, 1971, 52 : 45 - &
  • [4] CLINICAL-TRIALS IN PSYCHOSOCIAL MEDICINE - METHODOLOGIC AND STATISTICAL CONSIDERATIONS .1. INTRODUCTION
    SCHMALE, AH
    [J]. CANCER TREATMENT REPORTS, 1980, 64 (2-3): : 441 - 443
  • [5] Introduction to Statistical Methods for Clinical Trials
    Albright, David L.
    [J]. RESEARCH ON SOCIAL WORK PRACTICE, 2010, 20 (02) : 243 - 244
  • [6] STATISTICAL AND ETHICAL CONSIDERATIONS IN CLINICAL-TRIALS
    ALMAN, JE
    [J]. COMMUNITY DENTISTRY AND ORAL EPIDEMIOLOGY, 1980, 8 : 267 - 272
  • [7] STATISTICAL CONSIDERATIONS FOR CLINICAL TRIALS IN AUTOIMMUNE DISEASES
    Labopin, Myriam
    [J]. BONE MARROW TRANSPLANTATION, 2010, 45 : S15 - S15
  • [8] STATISTICAL AND ETHICAL CONSIDERATIONS IN DESIGN OF CLINICAL TRIALS
    GEHAN, EA
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1974, 100 (06) : 527 - 527
  • [9] Statistical Considerations for the Next Generation of Clinical Trials
    Wu, Wenting
    Shi, Qian
    Sargent, Daniel J.
    [J]. SEMINARS IN ONCOLOGY, 2011, 38 (04) : 598 - 604
  • [10] Statistical Considerations on Subgroup Analysis in Clinical Trials
    Alosh, Mohamed
    Fritsch, Kathleen
    Huque, Mohammad
    Mahjoob, Kooros
    Pennello, Gene
    Rothmann, Mark
    Russek-Cohen, Estelle
    Smith, Fraser
    Wilson, Stephen
    Yue, Lilly
    [J]. STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2015, 7 (04): : 286 - 304